WARFARIN SODIUM (warfarin sodium) by Teva is k-dependent clotting factors, which include factors ii, vii, ix, and x, and the anticoagulant proteins c and s. Approved for pulmonary embolism, atrial fibrillation, further extension of the formed clot and 2 more indications. First approved in 1997.
Drug data last refreshed 19h ago
K-dependent clotting factors, which include Factors II, VII, IX, and X, and the anticoagulant proteins C and S. Vitamin K is an essential cofactor for the post ribosomal synthesis of the vitamin K-dependent clotting factors. Vitamin K promotes the biosynthesis of γ-carboxyglutamic acid residues in…
Worked on WARFARIN SODIUM at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.